Review

Active Surveillance: Treatment Modality that Expect Attention for Localized Prostate Cancer
  • Tayyar Alp Özkan1
  • Özdal Dillioglugil
Bull Urooncol 2014; 13: 41-45
How affected Active Surveillance the quality of life in low-risk localized prostate cancer?
  • Ilker Çelen
  • Sinharib Çitgez
  • Talha Mu¨ezzinoglu
Bull Urooncol 2014; 13: 63-66
Active surveillance in low risk prostate cancer
  • Ozan Bozkurt
  • Ömer Demir
Bull Urooncol 2013; 12: 76-79
Treatment options in low-intermediate risk prostate cancer
  • Saadettin Yilmaz Eskiçorapçi
  • Deniz Bolat
Bull Urooncol 2013; 12: 80-85
Active surveillance for localized prostate cancer
  • Ilker Tinay
  • Levent Türkeri
Bull Urooncol 2012; 11: 114-118
Relationship between active surveillance / watchfull waiting and quality of life in localised prostate cancer
  • Ilker Çelen
  • Yasin Ceylan
Bull Urooncol 2013; 12: 123-126
Active Surveillance in Prostate Cancer
  • Volkan İzol
  • Nebil Akdoğan
Bull Urooncol 2017; 16: 127-132 DOI: 10.4274/uob.820
Active Surveillance-Factors Affecting the Treatment Decision: 3M: “Marker”, “Mapping”, “MRI”
  • Ender Özden
  • Mehmet Necmettin Mercimek
Bull Urooncol 2015; 14: 156-160 DOI: 10.4274/uob.379
Active Surveillance in Prostate Cancer: Can We Expand the Indications?
  • Hacı Murat Akgül
  • Asgar Garayev
  • İlker Tinay
Bull Urooncol 2016; 15: 163-166 DOI: 10.4274/uob.619

About Journal

Forms

Useful Links

Applications